A study published in Nature Aging has revealed a promising new drug candidate that may help combat metabolic ...

Semaglutide, a drug commonly taken for weight loss, showed marked benefits for most patients in a trial for metabolic dysfunction-associated steatohepatitis (MASH) ...

Disparities in prescribing semaglutide and tirzepatide for obesity reveal social factors affecting access and highlight the ...

Adverse pregnancy outcomes (APOs) mediate a small proportion of the association between prepregnancy obesity and cardiovascular disease (CVD) risk in midlife.

The benefit of GLP-1 therapy couldn’t be explained by weight loss, suggesting that some pleiotropic effects may be at work.

Approved by India’s apex drug regulatory body, the weight-loss drug is a once-weekly injection priced at Rs 4,375 for a 5 mg ...

Sugar, once the shining "white gold" of global trade, now stands at the heart of one of the biggest health challenges worldwide. It has become the key driver of obesity, diabetes, heart diseases, ...

Eli Lilly announced clinical trial results this week for a daily pill to treat obesity and diabetes. Its name is absolutely ...

A study conducted at Namseoul University in South Korea has found that tetrahydrocannabivarin (THCV), a non-psychoactive cannabinoid found in marijuana, could offer therapeutic benefits for those with ...

Your Body Mass Index (BMI) is often an indicator to diagnose obesity. Combating obesity is paramount to overall health. According to The National Health Institute, 1 in 3 adults are considered ...

The FDA, led by Robert F. Kennedy Jr. and Marty Makary, plans to eliminate synthetic food dyes from the U.S. food supply due ...

Health Secretary Robert F. Kennedy Jr. and FDA Commissioner Marty Makary said on Tuesday that the agency plans to remove ...